依达拉奉联合苦碟子治疗脑梗塞的临床疗效
王群;李彬;王彩霞
【期刊名称】《中国继续医学教育》 【年(卷),期】2015(000)026
【摘要】目的：观察依达拉奉联合苦碟子治疗脑梗塞的临床疗效。方法将108例急性脑梗死患者随机分为观察组和对照组，分别采用依达拉奉联合苦碟子治疗和单纯使用依达拉奉治疗，观察治疗前后运动功能（FMA评分），血液流变学改善情况和比较临床疗效。结果治疗14 d后，观察组和对照组FMA评分分别为（68.54±21.35）分和（44.27±12.65）分，两组患者FMA评分均较治疗前升高，观察组升高的幅度大于对照组，P＜0.05，差异具有统计学意义。治疗后观察组血浆粘度、全血黏度、纤维蛋白原、红细胞聚集指数改善情况优于对照组，P＜0.05，差异具有统计学意义。观察组总有效率92.6%高于对照组79.6%，P＜0.05，差异具有统计学意义。结论依达拉奉联合苦碟子治疗脑梗塞，临床疗效显著。%Objective To observe the clinical effect of edaravone combined with kudiezi injection in treatment of cerebral infarction.Methods Selected 108 cases of patients with acute cerebral infarction were randomly divided into the observation group and the control group, respectively with edaravone combined with bitter plate treatment and simple edaravone treatment and observed clinical curative effect. Results The FMA scores of the two groups respectively (68.54±21.35) scores and (44.27±12.65) scores there were higher than before treatment 14 days, and the observation group were higher than
依达拉奉联合苦碟子治疗脑梗塞的临床疗效
